1) prostatic stromal hyperplasia
前列腺间质增生
1.
To establish the prostatic stromal hyperplasia model of rats,male Wistar rats were randomly distributed into eight groups: Normal group(group N),castrated group(group C),castrated and estradiol(E) or testosterone(T) treated group(group C+E or group C+T),and castrated groups treated with both E and T in different ratio(group C+E/T,E/T=1∶50,1∶100,1∶200 and 1∶300).
为建立前列腺间质增生的动物模型,将大鼠随机分为假手术组、去势组、去势+雄激素组、去势+雌激素组、去势+不同比例的雌/雄激素组(1∶50,1∶100,1∶200,1∶300),考察各实验组的前列腺指数、组织切片的形态学和平滑肌特异蛋白免疫组化染色的变化。
2) prostatic hyperplasia
前列腺增生
1.
Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia;
经尿道等离子体双极电切术治疗前列腺增生
2.
Transurethral electro resection for prostatic hyperplasia with small volume:A report 30 cases;
经尿道电切治疗小体积前列腺增生30例
3.
A comparative study and evaluations on the results of TURP and transrectal high intensity focused ultrasound (HIFU) for the treatment of benign prostatic hyperplasia;
经直肠高能聚焦超声与经尿道前列腺切除术治疗前列腺增生症近期疗效比较
3) Prostate hyperplasia
前列腺增生
1.
The significance of fibroblast growth factor 7 mRNA expression in benign prostate hyperplasia tissue;
成纤维细胞生长因子-7在前列腺增生组织中的表达
2.
Expression effect study of Xianjia prescription on prostate s bcl-2 and bax in benign prostate hyperplasia rats;
仙甲汤对前列腺增生大鼠前列腺组织bcl-2及bax表达影响的研究
3.
Detection of serum prostate specific antigen in cases of prostate hyperplasia;
前列腺增生患者前列腺特异性抗原测定
4) Benign prostatic hyperplasia
前列腺增生
1.
Treatment of senior and high risk benign prostatic hyperplasia by transurethral electrovaporization and resection of prostate;
高龄高危前列腺增生经尿道电汽化联合电切的临床探讨
2.
Effect of Xianjia prescription on the expression of FAS in rats prostate exponent of benign prostatic hyperplasia;
仙甲汤对实验性前列腺增生大鼠前列腺组织FAS蛋白表达的影响
3.
Transurethral electrovaporization of prostate for treatment of benign prostatic hyperplasia and management of its complications(a report of 612 cases);
经尿道前列腺电汽化术治疗良性前列腺增生及并发症的防治(附612例报告)
5) BPH
前列腺增生
1.
Efficacy Observation of the Chinese patent medicine Xiaojinwan in the treatment of BPH;
中成药小金丸治疗良性前列腺增生的疗效观察
2.
Microtraumatic TUVP for High Risk BPH in Elderly Patients;
高龄及高危前列腺增生症的微创经尿道前列腺电汽化术治疗
3.
Comparison of three lithotrity procedures for bladder stones in patients with BPH;
前列腺增生并膀胱结石三种腔内碎石方法比较
6) benign prostate hyperplasia
前列腺增生
1.
Effect of Luodalingtong capsules on PCNA and b-FGF in benign prostate hyperplasia rats;
罗达灵通胶囊对前列腺增生大鼠PCNA与b-FGF的影响
2.
Effect of Luodalingtong Capsula on benign prostate hyperplasia in rats;
罗达灵通胶囊对前列腺增生大鼠的影响
3.
Prophylaxis of inflammatory reaction and benign prostate hyperplasia with pollen extracts from Brassica campestric;
花粉提取物PBHF对炎症反应和前列腺增生的影响
补充资料：卵巢间质增生和卵泡膜增生
卵巢间质增生和卵泡膜增生
单纯卵巢间质增生所致双侧卵巢增大，即‘卵巢间质增生’；有黄素化间质细胞者称‘卵泡膜增生’。多发生于绝经后，可能因绝经后下丘脑-垂体功能紊乱，卵巢间质对垂体促性腺激素的一种增生性反应。常伴发糖尿病、高血压、肥胖、和甲状腺功能减退。临床上出现雌激素或雄激素过高现象。可伴子宫内膜增生甚至内膜癌等病变。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条